ALL |
META-ANALYSIS |
CITATIONS |
|
Meta-Analysis of Program Effects | ||||||||||||
Outcomes measured | No. of effect sizes | Treatment N | Adjusted effect size(ES) and standard error(SE) | Unadjusted effect size (random effects model) | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
ES | SE | Age | ES | p-value | ||||||||
Psychosis onset Initial development or onset of a diagnosed psychotic disorder such as schizoaffective disorder or schizophrenia. |
2 | 105 | -0.595 | 0.276 | 26 | -0.595 | 0.031 |
Bechdolf, A., Wagner, M., Ruhrmann, S., Harrigan, S., Putzfeld, V., Pukrop, R., Brockhaus-Dumke, A., . . . Klosterkötter, J. (2012). Preventing progression to first-episode psychosis in early initial prodromal states. The British Journal of Psychiatry, 200(1), 22-29.
Nordentoft, M., Thorup, A., Petersen, L., Øhlenschlaeger, J., Melau, M., Christensen, T. Ø., . . . Jeppesen, P. (2006). Transition rates from schizotypal disorder to psychotic disorder for first-contact patients included in the OPUS trial. A randomized clinical trial of integrated treatment and standard treatment. Schizophrenia Research, 83(1), 29-40.